This information is generalized and not intended as specific medical advice. Consult your healthcare professional before taking or discontinuing any drug or commencing any course of treatment.
Severe. These medicines may interact and cause very harmful effects and are usually not taken together. Contact your healthcare professional (e.g. doctor or pharmacist) for more information.
How the interaction occurs:
How the interaction occurs is not known.
What might happen:
Using these medicines together may cause your blood pressure to become very low and you may lose consciousness.
What you should do about this interaction:
Let your healthcare professionals (e.g. doctor or pharmacist) know right away that you are taking these medicines together. Let your doctor know if you have any dizziness, lightheadedness, or loss of consciousness.Your healthcare professionals may already be aware of this interaction and may be monitoring you for it. Do not start, stop, or change the dosage of any medicine before checking with them first.
1.Apokyn (apomorphine hydrochloride) US prescribing information. Tercica, Inc. July, 2010.
2.USFood and Drug Administration. FDA Drug Safety Communication: Abnormal heart rhythms associated with use of Anzemet (dolasetron mesylate). Available at: http://www.fda.gov/Drugs/DrugSafety/ucm237081.htm December 17, 2010.
3.Zofran (ondansetron) US prescribing information. GlaxoSmithKline September, 2014.
4.Drew BJ, Ackerman MJ, Funk M, Gibler WB, Kligfield P, Menon V, Philippides GJ, Roden DM, Zareba W. Prevention of torsade de pointes in hospital settings: a scientific statement from the American Heart Association and the American College of Cardiology Foundation. J Am Coll Cardiol 2010 Mar 2;55(9):934-47.
5.Bowron A. Practical considerations in the use of apomorphine injectable. Neurology 2004 Mar 23;62(6 Suppl 4):S32-6.